Lakefront Biotherapeutics (LKFT) Current Taxes (2014 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Current Taxes for 13 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.

• Quarterly Current Taxes rose 367.69% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 367.69% YoY) and the FY2025 annual result came in at $1.1 million, up 283.94% from the prior year.
• Current Taxes declined to $1.0 million in Q1 2026 per LKFT's latest filing, from $1.1 million in the prior quarter.
• Over the last five years, Current Taxes for LKFT reached as high as $3.0 million in Q1 2022 and fell as low as $63725.4 in Q4 2023.
• A 5-year average of $865545.5 and a median of $397146.0 in 2025 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2024 — Current Taxes tumbled 94.74% — and 2026, when it jumped 367.69%.
• Year by year, Current Taxes stood at $1.2 million in 2022, then plunged by 94.52% to $63725.4 in 2023, then soared by 344.64% to $283350.6 in 2024, then jumped by 283.94% to $1.1 million in 2025, then fell by 4.6% to $1.0 million in 2026.
• According to Business Quant data, Current Taxes over the past three periods registered $1.0 million, $1.1 million, and $397146.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.